Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions Comprising Plant Extracts and Use Thereof for Treating Inflammation

a technology of plant extracts and compositions, applied in the direction of plant ingredients, biocide, plant growth regulators, etc., can solve the problems of affecting the most basic motor skills, affecting the protection of immune responses, and a plethora of adverse effects

Inactive Publication Date: 2011-10-27
NUTRIQUINE +1
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0020]The present invention also provides a method of preventing, treating or both preventing or treating inflammation or a condition that results fr

Problems solved by technology

However, under pathological conditions these normally protective immune responses can be erroneously misdirected to damage the body's own tissues.
This activity can lead to a plethora of adverse outcomes, ranging from localized swelling and discomfort to organ failure (2, 3).
Such damage can lead to joint weakness, instability and visible deformities that, depending on the location of joint involvement, can interfere with the most basic motor skills.
The application of these therapies is further complicated by wide variations in their documented efficacy and safety.
However, complications such as gastric ulceration have seen the use of these agents decline in favour of safer alternatives.
The use of corticosteroids in the treatment of OA is controversial because, although they reduce synovitis and inflammatory changes in the cartilage, they are detrimental to cartilage health by decreasing proteoglycan and collagen production.
Presently, it is difficult to make recommendations as to which treatment is best for subjects because few head-to-head comparisons of these products have been made, emphasizing the need for continued well-designed experimental and clinical research to evaluate their efficacy and safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Carrageenin-Induced Acute Inflammation in Mice

[0068]Phenylbutazone, Celebrex, Naproxen and individual plant extract compositions as described in Table V were suspended / dissolved in a vehicle of 2% Tween 80.

[0069]Male CD-1 (Crl.) derived mice weighing 22±1 g were obtained from BioLasco Taiwan (under Charles River Laboratories Technology Licensee). All animals were housed in a controlled temperature (22° C.-24° C.) and humidity (60%-80%) environment with 12 hours light / dark cycles for at least one week prior to experimental use. The animals had free access to standard lab chow for mice (MF-18 (Oriental Yeast Co., Ltd., Japan) and Reverse Osmosis water was granted. All aspects of the study including housing, experimentation and disposal of animals were performed in general accordance with the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, D.C., 1996).

[0070]Groups of 5 CD-1 male mice were fasted overnight prior to use. The test substances were admi...

example 2

Methods of Treating Adjuvant-Induced Arthritis in Rats

[0072]The study was conducted in male Lewis rats obtained from Charles River Japan, Inc. The animals were housed in a controlled temperature (21° C.-24° C.) and humidity (54%-68%) environment with 12 hour light / dark cycles for at least 1 week prior to use. Rats had Laboratory Rodent Diet MF-18 (Oriental Yeast Co., Ltd., Japan) and water (reverse osmosis purified water) ad libitum. The entire study and animal conditions and manipulations were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, D.C., 1996).

[0073]Eight groups of 5 rats weighing approximately 210±10 g were used. Anti-inflammatory composition 5, Phenylbutazone, Celebrex, Dexamethasone and 2% Tween 80 were administered orally once daily for 5 consecutive days, with the first dose given one hour before Complete Freund's Adjuvant (CFA) challenge. Anti-inflammatory composition 5 was administered at 25 or 6...

example 3

Mono-Iodoacetate (MIA) Chemically-Induced Osteoarthritis in Rats

[0076]A total of seventy (70) male Sprague-Dawley rats plus five (5) spares (Harlan Sprague Dawley, Inc., Indianapolis, Ind., USA) were used. The animals were pathogen free and of approximately 12 weeks of age upon start of experiments. There were 10 animals per group. The animals were individually housed in clear polycarbonate plastic cages but received enrichment in the way of Enrich-o-cobs bedding. The animals were acclimated for a minimum of 7 days prior to the start of the experimental procedures. The temperature was maintained at 18-26° C. (64-79° F.) with a relative humidity of 30-70%. Animals had ad libitum access to certified Pico rodent diet and water (deionized water system).

[0077]Animals were allocated to the treatment groups as specified in Table VII based on baseline von Frey results. The mean values of the groups were then reviewed to ensure that the groups were homogeneous.

[0078]Animals were first anesth...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

Provided are compositions comprising Harpagophytum procumens (Devil's claw) root extract and Ribes nigrum (Black Currant) leaf or seed extract. Other components may also be included. Also provided are methods of preventing or treating inflammation or a condition that results from inflammation.

Description

FIELD OF INVENTION[0001]The present invention relates to anti-inflammatory compositions. More specifically, the present invention relates to anti-inflammatory plant extract compositions.BACKGROUND OF THE INVENTION[0002]Inflammation is a self-defensive reaction designed to eliminate or neutralize potentially damaging stimuli and restore tissue integrity following insult (1). Inflammation can also be a two-edged sword. Pro-inflammatory mediators usually play a role in controlling important physiological functions, such as the regulation of blood pressure, platelet aggregation and body-temperature. In acute conditions, such as infection, inflammation protects tissue against invading pathogens and promotes healing. However, under pathological conditions these normally protective immune responses can be erroneously misdirected to damage the body's own tissues. This activity can lead to a plethora of adverse outcomes, ranging from localized swelling and discomfort to organ failure (2, 3)....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/56A61K33/34A61P21/02A61P29/00A61P19/02A61K36/45A61K33/42
CPCA61K36/185A61K36/28A61K36/76A61K38/018A61K2300/00A61P19/02A61P21/02A61P29/00
Inventor CHAMBERLAND, GUYDEVAUX, CELINEBOLLEN, PETER
Owner NUTRIQUINE